29738 Federal Register / Vol. 63, No. 104 / Monday, June 1, 1998 / Notices

respondent to file compliance reports,

retain certain documents, and notify the

Commission of certain changes in its

corporate structure.

By direction of the Commission.

Donald S. Clark,

Secretary.

[FR Doc. 98–14420 Filed 5–29–98; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Committee on Vital and Health

Statistics; Meetings

Pursuant to the Federal Advisory

Committee Act, the Department of

Health and Human Services announces

the following advisory committee

meetings.

Name: National Committee on Vital and

Health Statistics (NCVHS), Subcommittee on

Health Data Needs, Standards, and Security.

Times and Dates: 10:00 a.m.-5:00 p.m.,

June 15, 1997.

Place: Room 505A, Hubert H. Humphrey

Building, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open.

Purpose: Under the Administrative

Simplification provisions of Pub. L. 104–191,

the Health Insurance Portability and

Accountability Act of 1996 (HIPAA), the

Secretary of Health and Human Services is

required to adopt standards for specified

transactions to enable health information to

be exchanged electronically. The law

requires that, within 24 months of adoption,

all health plans, health care clearinghouses,

and health care providers who choose to

conduct these transactions electronically

must comply with these standards. The law

also requires the Secretary to adopt a number

of supporting standards including standards

for code sets and classifications systems. The

Secretary is required to rely upon the

recommendations of the National Committee

on Vital and Health Statistics (NCVHS) in

complying with these provisions. The

NCVHS is the Department’s federal advisory

committee on health data, privacy and health

information policy.

On June 15, 1998, the NCVHS

Subcommittee on Health Data Needs,

Standards, and Security will hold a meeting

to review the progress of its work and plan

future activities. The Subcommittee will

discuss plans for addressing 1) the HIPAA

requirements relating to electronic data

interchange standards for claims attachments

and 2) NCVHS recommendations for

standards for clinical data and its electronic

interchange. The Subcommittee also will

consider possible comments on the

published Notices of Proposed Rulemaking

relating to the adoption of EDI standards for

health care administrative transactions. In

addition, the Subcommittee will discuss

approaches to the development of a

framework for procedure classification

systems, as well as plans for public hearings

on unique individual identifiers for use in

the health system. All topics and times are

tentative and subject to change. Please check

the NCVHS website, where a detailed agenda

will be posted prior to the meeting.

Contact Person for More Information:

Substantive program information as well as

summaries of NCVHS meetings and a roster

of committee members may be obtained by

visiting the NCVHS website (http://

aspe.os.dhhs/gov/ncvhs). You may also call

James Scanlon, NCVHS Executive Staff

Director, Office of the Assistant Secretary for

Planning and Evaluation, DHHS, Room 440–

D. Humphrey Building, 200 Independence

Avenue SW, Washington, DC 20201,

telephone (202) 690–7100, or Marjorie S.

Greenberg, Executive Secretary, NCVHS,

NCHS, CDC, Room 1100, Presidential

Building, 6525 Belcrest Road, Hyattsville,

Maryland 20782, telephone (301) 436–7050.

Note: In the interest of security, the

Department has instituted stringent

procedures for entrance into the Hubert H.

Humphrey Building by non-government

employees. Thus, individuals without

government identification cards may need to

have the guard call for an escort to the

meeting room.

Dated: May 26, 1998.

James Scanlon,

Director, Division of Data Policy, Office of

the Assistant Secretary for Planning and

Evaluation.

[FR Doc. 98–14291 Filed 5–29–98; 8:56 am]

BILLING CODE 4151–04–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 96N–0373]

Agency Information Collection

Activities; Submission for OMB

Review; Comment Request

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that the proposed collection of

information listed below has been

submitted to the Office of Management

and Budget (OMB) for review and

clearance under the Paperwork

Reduction Act of 1995 (the PRA).

DATES: Submit written comments on the

collection of information by July 1,

1998.

ADDRESSES: Submit written comments

on the collection of information to the

Office of Information and Regulatory

Affairs, OMB, New Executive Office

Bldg., 725 17th St. NW., rm. 10235,

Washington, DC 20503, Attn: Desk

Officer for FDA.

FOR FURTHER INFORMATION CONTACT:

Margaret R. Schlosburg, Office of

Information Resources Management

(HFA–250), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–1223.

SUPPLEMENTARY INFORMATION: In

compliance with section 3507 of the

PRA (44 U.S.C. 3507), FDA has

submitted the following proposed

collection of information to OMB for

review and clearance.

Request for Information From U.S.

Processors that Export to the European

Community (OMB Control Number

0910–0320—Reinstatement)

European Community (EC) is a group

of 15 European countries that have

agreed to harmonize their commodity

requirements to facilitate commerce

among member States. EC legislation for

intra-EC trade has been extended to

trade with non-EC countries, including

the United States. For certain food

products, including those listed below,

EC legislation requires assurances from

the responsible authority of the country

of origin that the processor of the food

is in compliance with applicable

regulatory requirements.

With the assistance of trade

associations and State authorities, FDA

requests information from processors

that export certain animal-derived

products (e.g., shell eggs, dairy

products, game meat, game meat

products, and animal casings) to EC.

FDA uses the information to maintain

lists of processors that have

demonstrated current compliance with

U.S. requirements and provides the lists

to EC quarterly. Inclusion on the list is

voluntary. EC member countries refer to

the lists at ports of entry to verify that

products offered for importation to EC

from the United States are from

processors that meet U.S. regulatory

requirements. Products processed by

firms not on the list are subject to

detention and possible refusal at the

port. FDA requests the following

information from each processor:

(1) Business name and address;

(2) Name and telephone number of

person designated as business contact;

(3) Lists of products presently being

shipped to EC and those intended to be

shipped in the next 6 months;

(4) Name and address of

manufacturing plants for each product;

(5) Names and affiliations of any

Federal, State, or local governmental

agencies that inspect the plant,

government-assigned plant identifier,

such as plant number, and last date of

inspection; and

(6) Assurance that the firm or

individual representing the firm and